Open any IPO article this week and the first number you will see, usually before the company's business, its financials, or even its price band, is the GMP. Grey market premium has become the single most quoted figure in Indian primary markets, treated almost like an official forecast of listing day gains. Given how many issues have hit the market lately, with a genuinely busy stretch we covered in our piece on 10 IPOs in one day and how to choose in a primary market overdrive, it is worth actually asking the question nobody stops to answer, is this number reliable, or is it just noise dressed up as data.

The honest answer is somewhere in between, and understanding exactly where requires looking at real cases rather than the theory alone.

What GMP Actually Is

Grey market premium is the price at which IPO shares, or more precisely the right to receive IPO shares, trade unofficially before the stock lists on the exchange. If a company's issue price is Rs. 100 and the GMP is quoted at Rs. 30, that suggests informal traders expect the stock to list somewhere around Rs. 130, a 30 percent premium.

This market operates entirely outside SEBI's regulatory framework. There is no exchange, no formal settlement system, and no legal enforceability behind these trades. Deals are typically settled in cash between local dealers, largely concentrated in a handful of cities, based on trust and reputation rather than any contract. That single fact, that GMP comes from an unregulated, thinly traded, informal network, is the root of everything else in this piece.

When GMP Actually Gets It Right

To be fair to GMP, it does work reasonably often, particularly for issues with strong underlying demand and clean fundamentals. ESDS Software is a genuinely good recent example. Its grey market premium signalled a strong listing, and the stock delivered almost exactly that, debuting around a 76 percent premium before continuing to climb sharply in the days that followed. We tracked a similar story with Tempsens Instruments listing at a 111 percent premium, another case where grey market chatter and actual listing day performance lined up closely.

In cases like these, GMP is functioning the way it is supposed to, as a rough, informal aggregation of demand signals from people who are actually putting money on the line ahead of listing. When subscription numbers are genuinely strong and institutional interest is real, GMP tends to track that reasonably well, which is part of why it gets quoted so heavily in the first place.

When GMP Gets It Badly Wrong

The problem is that the failures are just as real, and they tend to get far less attention once they happen. Our own coverage of Leap India's listing day, where shares fell 12 percent below the issue price, is a clean example of a stock that listed well below what grey market sentiment had implied going in. Purple Style Labs is another recent case we covered as part of our roundup of IPOs to watch that same week, where it listed at a discount even as other issues in the very same basket, including ESDS, delivered strong premiums.

Our piece on Lohia Corp's listing day, what worked and what didn't, captures this mixed reality well, since even within a single stock's debut, different parts of the grey market's implied expectations played out while others simply did not. And a couple of IPOs we flagged early carried names that turned out to be fair warnings in hindsight, our pieces on Horizon Industrial Parks' muted GMP and Juniper Green Energy's muted response both saw weak grey market interest translate fairly accurately into a weak actual response, which is at least GMP working correctly in the negative direction.

How GMP Predictions Have Actually Played Out

IPO	Grey Market Signal	What Actually Happened
ESDS Software	Strong, high premium expected	Listed near 76 percent premium, kept climbing
Tempsens Instruments	Strong premium expected	Listed at 111 percent premium
Leap India	Positive sentiment going in	Listed 12 percent below issue price
Purple Style Labs	Mixed sentiment among peers	Listed at a discount
Horizon Industrial Parks	Muted GMP flagged in advance	Weak listing, as signalled

The SME Segment Is Where GMP Gets Truly Unreliable

If mainboard IPOs show GMP working roughly half the time, the SME segment is where the cracks really show. This year, 21 SME IPO stocks turned into genuine multibaggers, numbers that make for great headlines. But the median return across all SME IPOs this year sits at just 3.9 percent, meaning a handful of spectacular winners are masking a much weaker typical outcome for most investors.

This gap exists partly because SME IPOs trade in genuinely thin volumes in the grey market, sometimes just a handful of deals a day. A small number of trades can move the quoted GMP dramatically without reflecting anything close to broad-based demand. Our coverage of the Hy-Tech Engineers IPO's 19x subscription and the retail frenzy behind it is a good example of a case where actual subscription data ended up telling a more complete story than the grey market number alone.

Why GMP Is Structurally Unreliable, Even When It Looks Precise

The core issue is not that GMP is meaningless, it is that it was never built to be a precise forecasting tool in the first place. A few structural reasons explain why:

First, it is a thin, informal market. A handful of large trades by a few dealers can move the quoted number sharply, especially for SME issues, without representing genuine broad demand. Second, GMP reacts to sentiment as much as fundamentals. Market wide mood, like the volatility we tracked in our piece on why the market fell on six separate triggers recently, can swing GMP on issues that have nothing to do with those triggers at all, purely because broader risk appetite shifted. Third, there is no regulatory oversight, which means there is no real accountability if a dealer's quote turns out to be wildly off, unlike, say, SEBI's own Credit Risk-o-meter framework for debt securities, which at least carries formal regulatory backing.

Fourth, and this is the part people underestimate most, GMP can become a self-fulfilling prophecy in the short term. If enough retail investors pile into an IPO purely because GMP looks attractive, that oversubscription itself can push up the listing price briefly, regardless of the company's actual fundamentals, only for the stock to correct once that momentum fades.

How to Actually Use GMP, Without Getting Burned

None of this means you should ignore GMP entirely, it simply means it should never be the only input in your decision. A more sensible approach treats GMP as one signal among several. Look at subscription numbers broken down by category, since strong QIB and anchor investor participation tends to be a far more reliable signal than the grey market number alone, since institutional money faces real due diligence before committing. Look at the company's actual financials and growth trajectory rather than just the premium chatter. And be genuinely more sceptical of GMP on SME issues specifically, given how thin that market is, than on larger mainboard listings with broader institutional participation.

It is also worth remembering that chasing a hot GMP number is a fairly classic version of the same emotional decision-making pattern we described in our piece on why 90 percent of traders lose money in the stock market, acting on a single attractive number without asking what is actually driving it. A large mega IPO like the ones we profiled in our Top 10 upcoming IPOs for 2026-27 piece will likely see GMP quoted heavily too, but for issues of that scale, institutional pricing and analyst coverage will matter far more to the eventual outcome than informal grey market chatter ever could.

This article is for informational purposes only and should not be construed as investment advice. Investments in the securities market are subject to market risks. Please read all related documents carefully and consult a registered financial advisor before making any investment decisions.

Frequently Asked Questions (FAQ)

1. What does IPO GMP actually mean?

Grey market premium is the unofficial price at which IPO shares trade before listing, indicating what informal traders expect the stock's listing price to be above or below the issue price.

2. Is GMP a regulated or official number?

No, GMP comes from an unregulated grey market with no exchange oversight, no formal settlement system, and no legal enforceability behind the trades.

3. Has GMP ever been wrong about an IPO's listing?

Yes, several IPOs including Leap India and Purple Style Labs listed below or contrary to what grey market sentiment had suggested beforehand.

4. Why is GMP less reliable for SME IPOs?

SME IPO grey markets trade in very thin volumes, so a small number of trades can swing the quoted GMP sharply without reflecting genuine broad based demand.

5. Should I ignore GMP completely when applying for an IPO?

Not necessarily, but it should be treated as one signal among several, alongside category wise subscription data and company fundamentals, rather than the sole basis for a decision.